Controversy

How much of reported IDH/glioma-subtype imaging prediction reflects genuine biology vs confounded/leaky pipelines

Evidence grade: WEAK — Supported only by weak or preliminary evidence.

computed from the encoded evidence by the Atlas grading rule.

Position A

IDH status has real radiologic correlates (T2-FLAIR mismatch, frontal location, less enhancement); DL models reach high internal AUC

Position B

T2-FLAIR mismatch is highly specific but low-sensitivity; whole-model DL claims rarely externally validated on scanner-diverse cohorts

Clinical stakes

WHO CNS5 requires molecular status; imaging surrogates could triage but not replace tissue

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Reviewed by Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Last updated 2026-07-01.

This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.